Cefalexin Capsule GMP Manufacturer Medicine

• Customization: Available
• Application: Internal Medicine
• Usage Mode: For oral administration
• Model NO.: 125mg
• State: Solid
• Shape: Capsules
• Type: Inorganic Chemicals
• Pharmaceutical Technology: Chemical Synthesis
• Drug Reg./Approval No.: 13022518
• Production Line: GMP Approved
• Transport Package: Carton
• Specification: 250mg
• Trademark: SHIMEN
• Origin: Hebei
• HS Code: 3004909099
• Production Capacity: 1000000

Product Description

Cefalexin Capsule
 

Name: Cephalexin Capsule
Structural formula: C₁₆H₁₇N₃O₄S·H₂O

Mol wt: 365.41
Description The product is capsule
Pharmacology and toxicity
l. Pharmacology  Cephalexin is one of the first ceflorins. antibacterial spectrum of which is similar with cefoxitin; but antibacterial activity is weaker than the latter. Excluding enterococcus, methicllin staphylococcus, pneumonia streptococcus, hemolytic streptococcus, and most of staphylococcus are sensitive to the product. And the product has good antibacterial effect for the Naxer bacterial; hemophilus influenza is seldom sensitive to the product. And the product has some effect for coliform, bacillus proteus and etc. Some bacterial show the tolerance to the product such as  enteric bacilli, bacteroid. Usually clostridial and coccobacteria are sensitive to the product. And anaerobe  G+  show medium sensitive to this product.
2.Toxicity   Fatal dose for half mice is 2600mg/kg.
Action and usage:
Used for the treatment of respiratory infection, urinary tract infection, and skin soft tissue infection caused by the sensitive bacterial such as acute tonsillitis, angina, tympanitis, nasosinustis, bronchitis, pneumonia and etc. The product is a kind of oral preparation, and not suitable for the treatment of serious infection.

Production Name	Dosage	Packing
Cefalexin Capsule	250mg	60capsules/box

Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.
The production lines have achieved full automation control and information control in the production process and logistics process and reached international advanced level by integrating the world's leading equipment and technology.
With product quality as its life, the Company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures and provides guarantee for the health of the majority of patients at home and abroad with excellent quality products and services.
The Company has a powerful R&D team and made a number of achievements in scientific research and undertaken many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment and accelerating the pace of technological innovation.
Large volume injection is the key products, tablets, capsules, small volume injection and other forms are manufactured also. Recently API has been put into production and sales. There are more than ten international advanced production lines for the large volume injection, its production scale, technology level, brand influence and economic benefit are on the forefront of domestic counterparts, and it has become one of China's top 100 pharmaceutical industry enterprises and China's top 10 chemical and pharmaceutical industry preparation export-oriented excellent enterprise brands for many consecutive years.
The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.